190 related articles for article (PubMed ID: 36370934)
1. Chronic Treatment with the Probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis BB12 Attenuates Motor Impairment, Striatal Microglial Activation, and Dopaminergic Loss in Rats with 6-Hydroxydopamine-induced Hemiparkinsonism.
Cuevas-Carbonell SG; Vásquez-Celaya L; García-López D; Granados-Patrón D; García-Miss MDR; Álvarez-Cervera FJ; Mut-Martín M; Parra I; Mendieta L; Salgado H; Alamilla J; Cruz-Bojórquez R; Ávila-Escalante ML; Aranda-González II; Góngora-Alfaro JL
Neuroscience; 2022 Dec; 507():79-98. PubMed ID: 36370934
[TBL] [Abstract][Full Text] [Related]
2. Chronic feeding with 3% dried raw blueberries (V. corymbosum) reduces apomorphine-induced rotations and striatal dopaminergic loss in hemiparkinsonian rats.
Parra-Paz VG; Calderón-Sauri A; Granados-Patrón D; Cuevas-Carbonell SG; García-López D; Dawn-Ojeda A; Mut-Martín M; Olivera-Castillo L; Álvarez-Cervera FJ; Salgado H; Alamilla J; García-Miss MDR; Vásquez-Celaya L; Aranda-González II; Góngora-Alfaro JL
Food Res Int; 2021 Feb; 140():110066. PubMed ID: 33648289
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective and Immunomodulatory Effects of Probiotics in a Rat Model of Parkinson's Disease.
Parra I; Martínez I; Vásquez-Celaya L; Gongora-Alfaro JL; Tizabi Y; Mendieta L
Neurotox Res; 2023 Apr; 41(2):187-200. PubMed ID: 36662412
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Sleeman IJ; Boshoff EL; Duty S
Neuropharmacology; 2012 Dec; 63(7):1268-77. PubMed ID: 22971544
[TBL] [Abstract][Full Text] [Related]
5. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
Liu H; Jia L; Chen X; Shi L; Xie J
Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
[TBL] [Abstract][Full Text] [Related]
6. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine.
Rodrigues RW; Gomide VC; Chadi G
Int J Neurosci; 2001 Jul; 109(1-2):91-126. PubMed ID: 11699344
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
Matsuura K; Makino H; Ogawa N
Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
[TBL] [Abstract][Full Text] [Related]
8. Characterization of graded 6-Hydroxydopamine unilateral lesion in medial forebrain bundle of mice.
Cui J; Zhao D; Xu M; Li Z; Qian J; Song N; Wang J; Xie J
Sci Rep; 2024 Feb; 14(1):3721. PubMed ID: 38355892
[TBL] [Abstract][Full Text] [Related]
9. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M
Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
[TBL] [Abstract][Full Text] [Related]
10. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
[TBL] [Abstract][Full Text] [Related]
12. ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.
Salvatore MF
J Neurochem; 2014 May; 129(3):548-58. PubMed ID: 24410633
[TBL] [Abstract][Full Text] [Related]
13. Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair.
Silva C; Fuxe K; Chadi G
J Neural Transm Suppl; 2009; (73):185-202. PubMed ID: 20411778
[TBL] [Abstract][Full Text] [Related]
14. Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease.
Parra I; Martínez I; Ramírez-García G; Tizabi Y; Mendieta L
Neurotox Res; 2020 Jan; 37(1):1-11. PubMed ID: 31478124
[TBL] [Abstract][Full Text] [Related]
15. Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior.
Carman LS; Gage FH; Shults CW
Brain Res; 1991 Jul; 553(2):275-83. PubMed ID: 1681983
[TBL] [Abstract][Full Text] [Related]
16. Nasal application of kisspeptin-54 mitigates motor deficits by reducing nigrostriatal dopamine loss in hemiparkinsonian rats.
Sinen O; Sinen AG; Derin N; Aslan MA
Behav Brain Res; 2024 Jun; 468():115035. PubMed ID: 38703793
[TBL] [Abstract][Full Text] [Related]
17. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
19. Behavioral tests predicting striatal dopamine level in a rat hemi-Parkinson's disease model.
Miyanishi K; Choudhury ME; Watanabe M; Kubo M; Nomoto M; Yano H; Tanaka J
Neurochem Int; 2019 Jan; 122():38-46. PubMed ID: 30419255
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.
Gui ZH; Liu J; Wang Y; Ali U; Wang T; Chen L
Chin J Physiol; 2011 Apr; 54(2):96-104. PubMed ID: 21789890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]